Bristol-Myers Squibb Company
COMPOSITIONS AND METHODS FOR PRODUCING A COMPOSITION
Last updated:
Abstract:
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
Status:
Application
Type:
Utility
Filling date:
25 Nov 2020
Issue date:
12 Aug 2021